Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 352

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 352
---
  |
|                                                                       |     |   |           |     |   |           |     |         |     |                             |     | Risk-free rate of 5.09% determined using the expected life assumptions.                                       |     | The higher the risk-free rate the higher the fair value. |
| Total                                                                 |     | £ | 1,159,000 |     | £ | 4,160,000 |     |         |     |                             |     |                                                                                                               |     |                                                          |

Changing the unobservable
risk-free rate input to the valuation model by 10% higher while all other variables were held constant, would not impact the carrying
amount of shares (2023: nil).

There were no transfers
between Level 1 and 2 in the period.

The financial liability
measured at fair value on Level 3 fair value measurement represents consideration relating to warrants issued in May 2024, December 2023,
June 2023, May 2020 and October 2019 as part of Private Placements, Registered Direct offerings and the Warrant Inducement Transaction.

| 9. | Share capital and reserves |

| Schedule of detailed information about share capital 
 Authorised, allotted and fully                       
 paid – classified as equity                          |     | As at June 30, 2024 
    unaudited Number |     | As at June 30, 2024 
         unaudited £ |     | As at December  31, 2023 Number |     | As at December 
     31, 2023 £ |
|:-----------------------------------------------------|:----|--------------------:|:----|--------------------:|:----|--------------------------------:|:----|---------------:|
| Ordinary shares of                                   
 £0.001 each                                          |     |       3,626,112,922 |     |           3,626,113 |     |                   1,189,577,722 |     |      1,189,578 |
| ‘A’ Deferred shares of £1 each                       |     |           1,000,001 |     |           1,000,001 |     |                       1,000,001 |     |      1,000,001 |
| ‘B’ Deferred shares of £0.001                        |     |       4,063,321,418 |     |           4,063,321 |     |                   4,063,321,418 |     |